Autres langues Hester Biosciences Limited NSE India S.E.

Actions

HESTERBIO

INE782E01017

Marché Fermé - NSE India S.E. Autres places de cotation 09:11:33 18/05/2024			Varia. 5j.	Varia. 1 janv.
1 761 ^INR	-0,92%		+2,13%	+20,80%

10/05	Transcript : Hester Biosciences Limited, Q4 2024 Earnings Call, May 10, 2024
10/05	Hester Biosciences Limited annonce ses résultats pour le quatrième trimestre et l'exercice clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Hester Biosciences' Consolidated Net Profit Rises in Fiscal Q4; Shares Jump 4%	10/05
Hester Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	10/05
Hester Biosciences Limited Proposes Dividend for the Financial Year 2023- 24	10/05
Hester Biosciences Names COO	29/02
Hester Biosciences Limited Announces Executive Changes	29/02
Hester Biosciences Sees Sharp Decline in Fiscal Q3 Consolidated Profit	02/02
Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02/02
CARE Ratings Keeps BBB+ Rating on Hester Biosciences' Bank Financing; Outlook Stable	03/01
Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	07/11
Hester Biosciences Limited Recommends Dividend for the Financial Year 2022-23, Dividend Payment Date on or After Monday, 25 September 2023	23/08/23
Hester Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	08/08/23
Hester Biosciences Limited Announces Board Appointments	27/06/23
Hester Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	17/05/23
Hester Biosciences Limited Recommends Dividend for the Financial Year 2022-23	17/05/23
Hester Biosciences Limited Announces Resignation of Directors	27/03/23
Hester Biosciences Limited Reports Earnings Results for the Nine Months Ended December 31, 2022	31/01/23
Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	31/01/23
Hester Biosciences Limited completed the acquisition of 22.5% stake in Thrishool Exim Limited.	31/12/22
Hester Biosciences Acquires Indigenous Technology for Avian Influenza Vaccine	28/12/22
Hester Signs Agreement Towards Receiving Indigenously Developed Technology from Indian Council of Agricultural Research	28/12/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hester Biosciences Limited NSE India S.E.

Actions

HESTERBIO

INE782E01017

Autres langues

Filtres